Status:
UNKNOWN
Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET
Lead Sponsor:
The Second Hospital of Nanjing Medical University
Collaborating Sponsors:
Nanjing Medical University
Wuxi No. 2 People's Hospital
Conditions:
Fecal Microbiota Transplantation
Bowel Obstruction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The etiology of bowel obstruction is usually diagnosed by imaging techniques such as MSCTE,MRE, et al, which have some disadvantages. For example, in order to obtain better image quality, MSCTE（Multi-...
Eligibility Criteria
Inclusion
- Symptoms of intestinal obstruction such as abdominal pain, abdominal distension, nausea, vomiting, cessation of anal exhaust and defecation；
- Abdominal X-ray or plain CT showed signs of intestinal obstruction;
- Participants suspected with intestinal stricture according to the recent lower GI endoscopy；
- Voluntarily sign written informed consent.
Exclusion
- Signs of peritonitis, perforation or massive hemorrhage of digestive tract;
- Accompanied with severe heart, brain, lung and kidney dysfunction, unable to take lower GI endoscopy;
- Allergic to laxatives or iodine contrast agents;
- Pregnant women;
- Confirmed or suspected claustrophobia;
- Inability to understand or provide informed consent
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05253222
Start Date
March 1 2022
End Date
June 1 2023
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210011